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 Few findings in psychological science are as well replicated as evidence that stress precipitates 
depression. A wealth of evidence supports dysregulation of two major stress response systems—
the hypothalamic-pituitary-adrenal (HPA) axis and its cortisol biomarker, and the sympathetic 
nervous system (SNS) with its salivary alpha-amylase (sAA) biomarker—as complicit in the 
etiology of depression risk. Prior research points to genetic variation as one source of individual 
differences within these systems. Although recent work emphasizes additive approaches to 
genetics, almost no research has examined if additive genetic risk in the HPA axis (HPA 
multilocus genetic profile score; MGPS) influences responding to lab-based stress exposure. 
Similarly, despite neurobiological connections between the HPA and SNS, no work has tested 
whether additive HPA-related genetic risk influences SNS reactivity to stress, or whether 
vulnerability in both systems, indicated by HPA-related genetic risk and SNS hyperreactivity, 
might work together to predict cortisol reactivity to stress. Using a diathesis stress framework to 
test responding to negative evaluative psychosocial stress, I examined whether an additive HPA 
MGPS: 1) predicts blunted cortisol reactivity, 2) predicts heightened sAA reactivity, and 3) 
interacts with heightened sAA reactivity to predict blunted cortisol reactivity. Findings indicated 
that an HPA MGPS did not significantly moderate the relationship between stress condition and 
cortisol or sAA reactivity respectively. However, sAA reactivity and HPA MGPS moderated the 
relationship between stress condition and cortisol reactivity. Findings help explicate how 
individual differences across two stress responsive systems influence cortisol reactivity. 
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CHAPTER I: INTRODUCTION 
 
Major Depressive Disorder (MDD) is one of the most burdensome diseases in the world, 
affecting over 322 million people across their lifetime (WHO, 2017). MDD exacts such a burden 
in part due to its chronicity (WHO, 2017), as well as its relative ubiquity across the lifespan 
(Kessler et al., 2006). Strikingly, about 800,000 people with MDD die by suicide annually 
(WHO, 2017). There remains an urgent need to elucidate risk factors of depression. Compelling 
evidence demonstrates a strong association between stressful life events and the development of 
a major depressive episode (Hammen, 2005; Kendler et al., 1999). However, not all people who 
experience a stressful life event will develop depression; many remain resilient, calling for 
examination of individual differences in stress responses. Differences in key stress response 
systems, namely the hypothalamic-pituitary-adrenal (HPA) axis through blunted cortisol and 
sympathetic nervous system (SNS) through elevated salivary alpha-amylase (sAA), have been 
linked to heightened risk for stress-related psychopathology, including MDD (Ali & Pruessner, 
2012; Burke, Fernald, et al., 2005; Gotlib et al., 2008; McEwen, 1998).  
 Additionally, dominant etiological models of stress-related psychopathology suggest that 
stress exposure and preexisting risk factors including genetic vulnerability act together to 
precipitate disorder onset, known as diathesis stress theory (Monroe & Simons, 1991).  Gene by 
environment interaction research (GxE) is a well-used method to model diathesis stress theory 
(Colodro-Conde et al., 2018). Furthermore, GxE interaction research demonstrates that genetic 
variation in the HPA axis moderates the impact of stress exposure on risk for depression (see 
Normann & Buttenschøn, 2019 for a systematic review). MDD is moderately heritable, with a 
meta-analytic point estimate of 37% for the contribution of genetic variation (95% CI = 31 - 
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42%; Sullivan et al., 2000). However, like other genetically complex diseases, MDD is 
considered “polygenic,” such that risk for depression is derived from many genes with small 
contributions, which contribute to risk in a primarily additive manner (Colodro-Conde et al., 
2018). To better conform to these theoretical assumptions of behavior genetic risk, researchers 
have transitioned from focusing on single genes in GxE research to using additive variables, such 
as multilocus genetic profile scores (MGPS), which account for the collective effect of multiple 
empirically- and theoretically-identified single nucleotide polymorphisms (SNPs). Indeed, 
several MGPS developed using HPA-related genetic variation have been linked with depression 
and related outcomes (Di Iorio et al., 2017; Feurer et al., 2017; Pagliaccio et al., 2014; 2015a; 
2015b ; Starr & Huang, 2019).  
Despite this advance, insufficient work documents the relationship of an MGPS in the 
HPA axis (HPA MGPS) with cortisol reactivity, and with other related physiological outcomes. 
Evidence from human (Bauer et al., 2002; Gordis et al., 2008; Rotenberg & McGrath, 2016) and 
animal (Itoi et al., 2004; Jedema & Grace, 2004) studies suggests physiological and functional 
interconnectedness between the HPA axis and the SNS. Despite that genetic variants in the HPA 
axis are active in brain regions that also regulate the SNS (Modell, 1998), only one study has 
examined whether genetic vulnerability in the HPA axis influences SNS stress responses (DeRijk 
et al., 2006), though no previous studies have used an additive approach. Moreover, multisystem 
asymmetry theory (Bauer et al., 2002) asserts that SNS and HPA axis activity act together to 
enhance psychopathology risk. If this is the case, it may be that those with the greatest HPA 
genetic vulnerability and the highest SNS reactivity will have the most pronounced cortisol 
blunting in the context of stress exposure. 
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The present study tested the extent to which an HPA axis multilocus genetic score 
consisting of 14 previously studied polymorphisms moderates the relationship between stress 
exposure (either a lab-based negative evaluative social stress test or a non-stressful control 
condition) and reactivity in cortisol and sAA, respectively, in a non-depressed, emerging adult 
sample to elucidate risk pathways for depression risk. It further tests whether the combination of 
higher MGPS and sAA responses predicts blunted cortisol reactivity in the context of negative 
evaluative stress. 
The Stress Response  
In the context of acute environmental stress, threatening stimuli are processed through 
neuronal circuitry in the prefrontal cortex and limbic system, which importantly includes the 
hypothalamus (McEwen, 1998; McEwen & Sapolsky, 1995). Activation of the hypothalamus 
triggers a cascade of coordinated, sequential responses, starting with immediate activation of the 
SNS and followed by activation of the HPA axis within minutes (McEwen, 1998; Sapolsky et al., 
2000). These systems coordinate to modulate stress reactivity and maintain homeostasis through 
secretion of catecholamines (norepinephrine and epinephrine) from the SNS, and glucocorticoids 
(cortisol) from the HPA axis (Sapolsky et al., 2000). Among healthy individuals, a moderate 
secretion of these hormones is adaptive for responding to acute stressors maintaining 
homeostasis, which is termed “allostasis” (McEwen, 1998). However, elevations in the SNS and 
HPA axis that are too frequent, large, or prolonged are thought to lead to physiological wear and 
tear known as “allostatic load” (McEwen, 1998; McEwen, 2004; McEwen & Sapolsky, 1995). 
Critically, patterns of dysregulation of the SNS and HPA axis as a result of allostatic load, are 
thought to contribute to enhancing risk for depression (Ali & Pruessner, 2012; Bauer et al., 2002; 
Gordis et al., 2008).  
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Sympathetic Nervous System and Salivary Alpha-Amylase 
 In recent years, researchers have employed collection of salivary alpha-amylase (sAA) to 
measure SNS activity in response to stressful stimuli as an alternative to indices such as heart 
rate, blood pressure, skin conductance, or plasma collection for catecholamine concentration 
(Nater et al., 2006; Schumacher et al., 2013).  Alpha-amylase is a salivary protein produced by 
acinar cells and is secreted from the salivary glands and is thought to be regulated by the 
autonomic nervous system. Under unstimulated circumstances, salivary glands are more 
innervated by parasympathetic nerves relative to SNS activity. By contrast, under “stimulation” 
such as psychosocial stress, sAA is more innervated by the SNS (Granger & Taylor, 2020; Nater 
& Rohleder, 2009). Specifically, activation of the SNS in response to psychological stress 
stimulates beta-adrenergic receptors on salivary acinar cells in the oral cavity (Granger & Taylor, 
2020).  
The utility of sAA as an index of the SNS emerged from previous studies, which 
demonstrated that concentrations of sAA could be used to reliably predict sympathetic 
catecholamine levels, such as norepinephrine in response to lab-based physiological stress 
(Chatterton et al., 1996). As it pertains to psychological stressors,  prior work demonstrates that 
sAA increased along with other sympathetic indicators (e.g., shortened pre-ejection period 
“PEP”) in response to a lab-based psychological stressor (Bosch et al., 2003). Nater et al., (2006) 
observed concurrent increases in sAA secretions and sympathetic tone (LF/HF; a ratio of 
sympathetic heart rate to parasympathetic heart rate) in response to psychosocial stress (Nater et 
al., 2006). Finally, prior work demonstrates that healthy adult participants have elevated sAA 
reactivity in response to a psychosocial stress test (Balodis et al., 2010; Thoma et al., 2012). 
Thoma and colleagues (2012) concurrently examined sAA reactivity and plasma norepinephrine, 
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the primary neurotransmitter utilized by the SNS, and found that sAA reactivity positively 
predicted plasma norepinephrine in response to the Trier Social Stress Test (psychosocial stress 
test), suggesting that sAA validly indexes SNS activity during stress.  
The appeal and frequent use of sAA stems from its non-invasiveness comparable to 
alternative methods involving blood collection (e.g., plasma) or electrophysiological methods 
(Nater & Rohleder, 2009; Nater et al., 2007). Its simultaneous collection with salivary cortisol 
also promotes feasibility while providing multisystem indices of bodily stress reactivity. Like 
cortisol, sAA also follows a diurnal cycle (Nater et al., 2007), however unlike cortisol, sAA 
reacts seconds after the onset of a stressor, and is collected sooner than peak cortisol reactivity 
(Schumacher et al., 2013).  Taken together, previous work suggests that sAA is a feasible, viable 
biomarker for representing changes in SNS activity in response to lab-induced psychosocial 
stress. 
Generally, the effect of stress exposure on sAA responses in populations at risk for 
depression and other stress-related psychopathology is a sparse and emerging literature. Prior 
studies examined the relationship between sAA and chronic stress, pointing to elevated sAA (Ali 
& Pruessner, 2012). Additional evidence points to dysregulated sAA reactivity in response to 
acute stress in samples with depressive risk factors, such as increased sAA in individuals with 
higher levels of trait rumination and neuroticism (Soliemanifar et al., 2018). Some previous 
evidence points to the contrary (Bagley et al., 2011). For example, Bagley et al., (2011) did not 
find differences in levels of sAA in healthy individuals with remitted depression versus controls 
in response to a lab-based psychosocial stressor. However, the authors note as a limitation that 
they collected sAA 10 minutes after the stressful task in order to prioritize obtaining peak 
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cortisol levels. As pointed out by the authors, the peak of sAA stress reactivity precedes peak 
cortisol levels (Nater et al., 2005), potentially explicating the lack of effect.  
Hypothalamic-Pituitary-Adrenal Axis and Cortisol Dysregulation 
Responses of the HPA axis unfold somewhat more slowly than those of the SNS, 
described above. Briefly, upon perception of acute threat, the hypothalamus secretes 
corticotrophin releasing hormone (CRH) from the paraventricular nucleus, which signals the 
pituitary gland to secrete adrenocorticotrophic hormone (ACTH) to the adrenal cortex, which 
further secretes glucocorticoids, known in humans as the stress-responsive hormone cortisol 
(McEwen, 1998; Sapolsky et al., 2000). This reactivity occurs superimposed on a diurnal rhythm 
for cortisol in which levels are higher in the morning, spike briefly upon awakening, and reach a 
nadir after bedtime (Granger & Taylor, 2020). The HPA axis maintains a negative feedback 
loop, where cortisol binds to glucocorticoid (GR) and mineralocorticoid (MR) receptors on the 
hippocampus and hypothalamus respectively, to either continue (if the threat is still present) or 
suspend cortisol secretion (McEwen, 2004).  In the context of chronic, ongoing threat, there is an 
overextension of the HPA axis response, which manifests as dysregulated secretion of cortisol 
and over time, markedly dampens the HPA axis (McEwen, 1998; Sapolsky et al., 2000). 
Moreover, in humans, cortisol levels peak around 15-30 minutes after the threat begins, and 
normalize to pre-stress levels 60-90 minutes later, provided that the threat abates (de Kloet et al., 
2005). Of importance, these patterns of dysregulation are implicated in the pathogenesis of 
depression, and therefore represent a risk factor (McEwen, 1998).  
While there is clear support for dysregulated cortisol reactivity as a marker of depression 
risk, the pattern of dysregulation—whether cortisol is overactive (elevated) versus underactive 
(blunted) in response to an acute stressor—is mixed. As it pertains to healthy individuals at risk 
 7 
for MDD, such as those with remitted depression, or with family members diagnosed with 
current MDD, some past research indicates elevated cortisol reactivity in response to an acute 
psychosocial stressor (Alexander et al., 2009; Höhne et al., 2014; Holsboer et al., 1995). 
However, a wealth of literature also paradoxically points to decreased or blunted cortisol 
reactivity in response to acute stress in healthy individuals at risk for depression (Ahrens et al., 
2008; Burke, Fernald, et al., 2005; Morris et al., 2014). Some of the observed variability in 
cortisol response may be attributable to differential contextual factors such as severity of the 
stressor or gender. For example, previous studies examining cortisol reactivity to acute 
psychosocial threat in individuals with remitted depression found blunted cortisol reactivity 
(Ahrens et al., 2008; Morris et al., 2014), while other studies examining remitted depression 
found blunted cortisol reactivity in women participants only (Bagley et al., 2011), suggesting the 
importance of examining gender differences in cortisol outcomes.  
Importantly, findings may also diverge based on stressor severity. For example, a 
previous study examining genetic risk of single variants associated with depression in non-
depressed young adults manifested as a blunted cortisol response to a lab-based stressor, where 
individuals were provided negative feedback on a task to induce psychosocial threat (Avery & 
Vrshek-Schallhorn, 2016). A study using the same genetic variants, but using a more mild 
manipulation of the same lab-based stress paradigm as Avery and Vrshek-Schallhorn (2016), 
found elevated cortisol levels rather than blunted (Brummett et al., 2012). These divergent results 
suggest important contextual differences, where the severity of acute stress exposure may 
influence whether at-risk individuals demonstrate hyper- or hypo-reactive cortisol responses, as 
described in the cortisol reactivity threshold model (Vrshek-Schallhorn et al., 2018). Critically 
for the present work, this model hypothesizes that depression risk factors will predict heightened 
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cortisol reactivity to mild or moderate stressors, but blunted cortisol reactivity to more robust 
stressors, such as the present study’s negative evaluative stress induction (discussed later). In this 
context, blunted cortisol could be seen as a failure to mobilize resources in response to 
psychosocial threat in people at risk for depression, a “giving up” response (Morris et al., 2014; 
Vrshek-Schallhorn et al., 2018). Thus, it is plausible that cortisol reactivity profiles would be 
blunted in the context of a robust, severe stressor in an at-risk sample. 
Gene by Environmental Interactions and Stress Reactivity 
Gene by environment (GxE) interaction models contend that stress-related 
psychopathology manifests through an interaction of genetic risk and an environmental stressor 
(Colodro-Conde et al., 2018; de Kloet et al., 2005). The theoretical framework supporting GxE 
interactions is known as diathesis stress theory (Monroe & Simons, 1991), which posits that 
environmental stressors activate a "diathesis” or biological vulnerability, and propagate risk of 
stress-related disorders, including depression (Colodro-Conde et al., 2018; Monroe & Simons, 
1991; Schotte et al., 2006). Furthermore, diathesis stress models espouse that the effect of the 
interaction between the individual vulnerability and stressor may be multiplicative compared to 
their combined separate effects (Monroe & Simons, 1991). Thus, a number of GxE studies have 
aimed to clarify the role of candidate genes in relevant biological systems including HPA axis 
genes (e.g., CRHR1, NR3C1, NR3C2, FKBP5; discussed below) in modulating stress reactivity 
(Binder, 2009; Bogdan et al., 2016; Christine Heim et al., 2009).  
Multilocus Genetic Profile Scores  
Gene by environment interaction research has been largely characterized by identification 
of theoretically selected single genetic variants, i.e., “candidate genes;” however, this approach 
has been criticized for its small effect sizes and small sample sizes leading to low-powered tests 
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(Dick et al., 2015), and for failing to conform to the additive assumptions of behavioral genetics 
(Nikolova et al., 2011). That is, behavioral genetic models assume polygenic risk for depression, 
in which many genes each with small effects contribute in a cumulative, additive fashion, rather 
than any single genotype having a large effect as observed in conditions with simple genetic 
bases (Colodro-Conde et al., 2018; Wray et al., 2012). The candidate gene field has moved 
toward additive genetic profiles, known as multilocus genetic profile scores (MGPS)—which 
represent cumulative risk profiles comprised of known genetic variants in a physiological system 
(Bogdan et al., 2016; Nikolova et al., 2011). The use of an MGPS may increase power because 
the approach uses continuous genetic variables in contrast to dichotomous variables typically 
used in the single candidate gene approach (Altman & Royston, 2006). Moreover, when MGPS 
are constructed from specific neurobiological systems and used to examine intermediate 
outcomes, or “endophenotypes” (Hasler et al., 2004) relevant to closely related systems, this may 
further enhance power. Specifically, predicting intermediate outcomes in genetic studies is 
thought to reduce error variance because of the relatively proximal relationship between genetic 
variables and intermediate outcomes, as compared to diagnostic outcomes (Hasler et al., 2004). 
Genes Impacting HPA Axis Functioning  
I will preface a review of the previously reported MGPS and their findings with a brief 
introduction to the genes and single nucleotide polymorphisms (SNPs) used, as well as their 
attendant function, as an orientation to the reader. Genes, polymorphisms, and coding 
information is provided in Table 1. 
CRHR1 
 Risk alleles include rs110402, rs7209436, rs242924, rs4792887, rs242939, rs1876828, 
and rs242941. The CRHR1 gene codes for corticotropin releasing hormone receptor 1 in the 
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pituitary gland (Liu et al., 2006)). Polymorphisms in CRHR1 have been associated with 
dysregulated cortisol levels in response to psychosocial stress (Christine Heim et al., 2009; Li et 
al., 2019; Ludwig et al., 2018), and with depressive symptoms (Bogdan et al., 2011; Davis et al., 
2018; Christine Heim et al., 2009; Ludwig et al., 2018). 
NR3C1 
 Risk alleles include rs41423247, rs10482605, and rs10052957. The NR3C1 gene 
encodes glucocorticoid (GR) receptors which are highly expressed in the hippocampus and other 
areas of the brain. Specifically, GRs have a low affinity but high capacity for cortisol and play a 
role in HPA axis regulation by downregulating cortisol levels when they are high, usually in the 
context of chronic or ongoing stressors (Zhe et al., 2008). When stressors are enduring, repeated 
occupation desensitizes GRs and compromises its downregulating function, permitting cortisol to 
remain chronically elevated, creating a host of downstream, potentially harmful sequelae, such as 
compromised immune function. This gene has been linked to dysregulated stress reactivity 
(Plieger et al., 2018) and depressive outcomes in multiple studies (Peng et al., 2018).  
NR3C2 
 Risk alleles include rs5522, rs2070951, and rs4635799. The NR3C2 gene codes for 
mineralocorticoid receptors (MR), which are highly expressed in the hippocampus and assist in 
the inhibition of the HPA axis. As opposed to GR, MR has high affinity for cortisol and is 
occupied under low to moderate amounts of cortisol such as in the context of acute or early 
stages of threat (Zhe et al., 2008). Polymorphisms have been found to alter MR activity and 
enhance depression in individuals with a history of early life adversity (de Kloet et al., 2016; 
Vinkers et al., 2015) and influence cortisol responses in the context of lab-based stressors 
(Gutiérrez-Zotes et al., 2019; de Kloet al., 2011; Plieger et al., 2018). Along with altered HPA 
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axis activity, a previous study demonstrated altered autonomic activity in carriers of the rs5522 
variant in response to the TSST (DeRijk et al., 2006). 
FKBP5 
 Risk allele includes rs1360780. The FKBP5 gene co-chaperones GR receptors. Variants 
of FKBP5 are associated with modulation of GR sensitivity to cortisol and impaired negative 
feedback in the HPA axis system related to decreased GR sensitivity (Binder, 2009). Possessing 
the FKBP5 variant suggests that there will be decreased binding of cortisol to GRs, which 
inhibits the negative feedback system of the stress response, prolonging HPA axis response and 
prolonging the “wear and tear” of GRs.  For this reason, FKBP5 is associated with risk for 
depression (Dam et al., 2019; Ising et al., 2019; Normann & Buttenschøn, 2019; Wang et al., 
2018). 
Established HPA MGPS 
The extant HPA MGPS literature reviewed below has collectively used 14 genetic 
variants located in (or very near) the four genes (CRHR1, NR3C1, NR3C2, FKBP5) previously 
described. The authors (Bogdan et al., 2016; Di Iorio et al., 2017; Pagliaccio et al., 2014, 2015a, 
2015b; Starr & Huang, 2019) adopted slightly different approaches to select candidate genes for 
their respective HPA MGPS. Table 2 provides a visual depiction of SNPs included previous 
studies of HPA MGPS, as well as SNPs included in the current study’s HPA MGPS. 
Pagliaccio et al., (2014, 2015a, 2015b) used an HPA MGPS comprised of 10 SNPs, 
including CRHR1 (rs4792887, rs110402, rs242941, rs242939, rs1876828), NR3C2 (rs5522), 
NR3C1 (rs41423247, rs10482605, rs10052957), and FKBP5 (rs1360780) across three studies. In 
Pagliaccio et al. 2014, the authors found that an HPA MGPS and early life stress interacted to 
predict hippocampal and amygdala volume in school-aged children, finding that children with 
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higher HPA MGPS and higher early life stress predicted volumes consistent with depressive 
profiles. The authors also found a main effect for HPA MGPS positively predicting cortisol 
activity, suggesting an HPA MGPS’s relation to depression risk. In Pagliaccio et al., 2015a, the 
authors tested whether HPA MGPS and childhood stress exposure independently or interactively 
predicted amygdala activity to cortical areas central to emotion regulation and anxiety processes 
in a sample of school-aged children. They found that higher HPA MGPS and higher early life 
predicted poorer functional connectivity in the amygdala, indicating depression risk in those with 
a higher MGPS relative to children with a lower MGPS. Finally, in Pagliaccio et al., 2015, the 
same HPA MGPS was used in concert with stress exposure to examine amygdala and 
hippocampus responses to fearful versus neutral activation in school-aged children. This study 
revealed key individual differences in how children with higher MGPS respond to negative 
emotional stimuli via amygdala and hippocampus activation, where factors such as sex and 
pubertal status moderated MGPS and cortical responsivity. Taken together, this characterization 
of a novel HPA MGPS demonstrated the first relationships of this score with depression related 
neurobiological outcomes. 
Di Iorio et al., (2017) used an HPA MGPS comprising 4 SNPs across 3 genes, including 
FKBP5 (rs1360780), CRHR1 (rs110402); and a NR3C2 (rs5522, rs4635799) “CT” haplotype 
(SNPs that tend to be inherited together) to examine whether an HPA MGPS moderates the 
relationship between early stress and both amygdala function and volume in a college-aged 
sample. The authors found that individuals with a higher HPA MGPS had higher threat-related 
amygdala reactivity compared to those with a low HPA MGPS.  The HPA MGPS in this study is 
smaller compared to previously discussed studies because the authors selected one SNP per gene 
(rather than multiple) to include in the HPA MGPS to equally weigh gene influence, and 
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therefore prioritized SNPs that were more well-characterized in the literature. Some SNPs of 
interest were also not available for microarray at the time this research was conducted and were 
unable to be included in the MGPS, such as the three NR3C1 variants noted in forthcoming 
studies described below. Lastly, the authors used fewer NR3C2 variants, as to their knowledge at 
that time, there were no other SNPs in the gene associated with HPA axis function, explicating 
their smaller MGPS.  
Feurer et al., (2017) used a similar HPA MGPS as Di Iorio and colleagues (2017) to 
examine acute stress and depressive symptoms in a sample of at-risk children; however, Feurer 
and colleagues included two additional CRHR1 variants in order to examine the CRHR1 
protective “TAT” haplotype, and they included a different SNP to examine an alternate NR3C2 
(rs5522, rs2070951) “CA” protective haplotype, yielding an HPA MGPS with 6 SNPs. Their 
study aims were to examine depressive symptoms in children of depressed mothers in the context 
of stress exposure (Feurer et al., 2017). The authors found that children of depressed mothers 
who had a higher MGPS and who experienced higher levels of interpersonal stress experienced 
heightened depressive symptoms compared to children with lower MGPS. Compared to 
Pagliaccio et al, (2014, 2015a, 2015b), Di Iorio et al., 2017 and Feurer et al., 2017; included 
additional SNPs in the NR3C2, CRHR1, and NR3C1 genes to examine additional variants related 
to depression phenotypes. While Feurer et al., (2017) found evidence that the “TAT” haplotypes 
were protective, this has not been consistent in the literature. For example, Davis et al., (2018) 
demonstrated that carriers of the same TAT haplotype demonstrated more pronounced cognitive 
symptoms of depression, compared to those without the haplotype, urging additional 
examination.  
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Starr and Huang (2019), mirrored Pagliaccio’s HPA MGPS, comprised of 10 SNPs in a 
sample of adolescents, and found a significant main effect of MGPS on depression symptoms. 
Similarly, HPA MGPS interacted with acute stress, chronic stress, and interpersonal childhood 
adversity, respectively, to predict depressive symptoms.   
Our approach aims to utilize the aforementioned studies’ HPA MGPS (Di Iorio et al., 
2017; Feurer et al., 2017; Pagliaccio et al., 2014; 2015a; 2015b; Starr & Huang, 2019) by using 
the same SNPs as previously reported to facilitate eventual meta-analysis, per recommendations 
(Vrshek-Schallhorn et al., 2015). Moreover, the current study aims to address extant gaps in the 
literature. First, all but one of the aforementioned HPA MGPS studies use adolescent and child 
samples (Feurer et al., 2017; Pagliaccio et al., 2014, 2015a, 2015b; Starr & Huang, 2019a). Only 
one study to the best of our knowledge, employs an HPA MGPS in a college-aged sample, which 
examined cortical and depressive outcomes (Di Iorio et al., 2017). Emerging adulthood, defined 
as ages 18 to 24, represents a salient developmental period with its own unique risk factors for 
depression (Lisznyai et al., 2014). This is in part due to the multiple transitions that typically 
occur in this phase including identity formation, career development, and relationship formation 
(Arnett, 2000). The consistently changing life circumstances are perceived differentially among 
emerging adults, with some experiencing symptoms of anxiety and depression in response 
(Lisznyai et al., 2014). Additionally, previous studies suggest that personality traits such as 
neuroticism, a substantiated risk factor for depression, is highest during emerging adult years 
(Aldinger et al., 2014). Taken together, emerging adulthood is a salient timepoint to examine 
depression risk. 
Second, most studies have examined depressive symptoms as an outcome, rather than 
stress reactivity directly, leaving a gap in understanding the mechanisms by which this genetic 
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vulnerability influences depressive risk. Pagliaccio et al. (2014) does examine cortisol reactivity 
using the Laboratory Temperament Assessment Battery, however, this examines temperament in 
response to both positive and negative/frustrating tasks, which can be ambiguous, rather than 
using an explicit negative evaluative manipulation that provides heightened psychosocial threat 
in addition to a putatively neutral control condition (Way & Taylor, 2010). These two gaps are 
critical, as HPA MGPS moderation of negative evaluative stress exposure predicting cortisol 
reactivity in an emerging adult sample has not yet been examined. A third gap, discussed below, 
pertains to probing the HPA MGPS’s influence on interrelationships between multiple stress 
responsive systems. A final gap is to examine the extent to which proposed haplotypes of “CA” 
and “TAT” buffer, or protect the effects of stress exposure on cortisol reactivity. 
Relationship between HPA Axis and SNS System 
Most investigations of stress response dysregulation have focused on the HPA axis and 
SNS as independent from one another (Bauer et al., 2002), but there are at least three compelling 
reasons to test their joint action: basic physiology, asymmetry theory, and prior evidence from 
stress induction studies.  
First, prior work suggests that the SNS and HPA axis are physically interconnected and 
coordinated in their response to stress, suggesting that it may be fruitful to examine them in 
tandem (Rotenberg & McGrath, 2016).  The physical interconnectedness of the HPA axis and 
SNS is supported by animal (Itoi et al., 2004; Reyes et al., 2005; Ziegler et al., 1999) and human 
studies (Engert et al., 2011; Rotenberg & McGrath, 2016). Animal evidence indicates that the 
SNS and HPA axis are reciprocally innervated, such that hypothalamic neurons (emanating from 
the paraventricular nucleus) modulate activity of the locus coeruleus (LC), which secretes 
norepinephrine (noradrenaline), the primary neurotransmitter of the SNS (Itoi et al., 2004; Reyes 
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et al., 2005). Similarly, norepinephrine (NE) releasing neurons in the brainstem stimulates CRH 
releasing neurons in the hypothalamus, which leads to ACTH and then cortisol release. 
Moreover, NE axons emanate to all elements of the HPA axis system (hypothalamus, prefrontal 
cortex, hippocampus, and amygdala; (Goddard et al., 2010). Ziegler and colleagues (1999) 
compellingly demonstrated that lesioning the LC, thus reducing norepinephrine release, 
diminished HPA axis activity in rodent models. Physiological evidence in humans echoes that in 
animals.  HPA axis variants have been shown to alter the structure and function of cortical brain 
structures that influence both SNS and HPA axis activity, such as CRH related variants in the 
hypothalamus (e.g., CRHR1 gene; Modell, 1998). These studies suggest functional and structural 
interconnectedness between the LC (critical to the SNS) and the HPA axis and support that 
genetic variation in the HPA axis may also influence SNS regulation.   
Second, theoretical models support examining HPA axis and SNS activity in tandem 
through statistical interactions, as prior work suggests that the two explain more variance in 
mental health outcomes considered together than considered separately (Bauer et al., 2002). 
Specifically, multisystem asymmetry theory (Bauer et al., 2002) suggests that the physiological 
interconnectedness between the SNS and HPA axis results in a pattern in which those with better 
mental health outcomes tend to have symmetric responding to threat from the SNS and HPA 
axis. By contrast, it predicts that those with adverse mental health outcomes (e.g., internalizing 
symptoms) will show asymmetric responding to threat in SNS and HPA axis biomarkers, such as 
increased cortisol in the context of low SNS activity, or low cortisol in the context of high SNS 
activity, in response to threat. Multiple studies across youth samples have demonstrated 
empirical support for multisystem asymmetry theory in children and adolescence (Gordis et al., 
2008; Martinez-Torteya et al., 2017). For example, Vigil et al. (2010) found among a group of 
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Hurricane Katrina survivors in late-adolescence/early-adulthood, that hurricane exposure and 
sAA activity moderated the relation between cortisol and internalizing behaviors, such that 
higher sAA and lower cortisol predicted higher internalizing behaviors, demonstrating 
theoretical support for asymmetry theory. Moreover, Gordis et al. (2008) found support for 
multisystem asymmetry theory, such that maltreated children showed elevated sAA and lower 
cortisol in response to a modified TSST compared to non-maltreated youth. The authors 
conceptualize the asymmetry as resulting from habituation of the HPA axis response to chronic 
stress exposure (e.g., attenuated response over time), while the SNS maintains a consistent, 
robust response to repeated threat. 
By contrast, the interaction between the SNS and HPA axis has been less frequently 
examined in adults. However, prior experimental stress induction models seem to support the 
asymmetry model. Andrews and Pruessner (2013) examined the interaction between the SNS 
and HPA axis activity. Healthy adults were given either an SNS inhibitor (propranolol) or a 
placebo prior to completing the TSST. In the propranolol condition, individuals had significantly 
reduced sAA and significantly increased cortisol compared to controls who were exposed to the 
same stressor, suggesting that inhibited SNS leads to elevated HPA activity.  From this, the 
authors proposed that the SNS may serve an inhibitory role over HPA axis activity (Andrews & 
Pruessner, 2013). Similarly, prior work has tested an opposite approach, administering either 
placebo or dexamethasone, which inhibits the peripheral HPA axis response, and administering 
the TSST to healthy, adult volunteers (Andrews et al., 2012). The dexamethasone group, which 
had a blunted cortisol response to the TSST, also had increased heart rate (an indicator of 
autonomic activity consistent with increased SNS activity) relative to controls (Andrews et al., 
2012).Taken together, these two studies suggest that the SNS and HPA axis depend upon each 
 18 
other’s action to respond to threat. The pattern of findings could be interpreted as SNS and HPA 
being mutually inhibitory, or instead, that when one insufficiently responds during threat, the 
other compensates with a larger response to marshal the resources necessary to face the threat.  
Two predictions follow. First, if 1) healthy individuals experience elevated sAA in 
response to the psychosocial threat, and 2) HPA axis genetic variation predicts blunted cortisol 
reactivity to psychosocial threat, and 3) multisystem asymmetry theory contends that discordant 
patterns between HPA axis and SNS reactivity indicate dysregulation, then we predict that 
individuals with higher HPA-related genetic risk will demonstrate blunted cortisol and elevated 
sAA in response to negative evaluative stress. Second, if SNS activity precedes and modulates 
HPA axis activity in response to stress, then we would predict that, an elevated sAA response 
will affect HPA axis reactivity by blunting cortisol in those with higher genetic variation. Thus, 
the present work will also examine whether sensitivity in the HPA axis indicated by genetic risk 
score is modulated by reactivity level in the SNS, indexed by sAA, to predict maximally blunted 
cortisol reactivity under acute psychosocial threat. 
Lab-Based Stress Paradigm 
To reliably elicit a neuroendocrine and sympathetic response in a controlled manner, the 
Trier Social Stress Test (TSST; Kirschbaum et al., 1993) was developed as a brief, objective, 
lab-based psychosocial stress paradigm. The TSST permits collection of a range of physiological 
indices, including neuroendocrine markers like cortisol, and sympathetic markers like sAA (see 
Allen et al., 2017 for a review). Moreover, lab-based psychosocial stress induction has been used 
to demonstrate GxE interactions successfully as evidenced by a meta-analysis of a serotonin 
system genetic variant and TSST reactivity (Miller et al., 2013), and further may provide 
evidence for genetic risks for depression (Avery & Vrshek-Schallhorn, 2016). 
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The TSST consistently elicits an HPA axis response through its simulation of acute, 
psychosocial threat using social evaluation and unexpected performance-based tasks (Allen et 
al., 2017). In brief, the standard TSST devotes 5 minutes each to speech preparation, delivering 
an extemporaneous speech on a typically self-evaluative topic, such as a job interview, and 
finally conducting arithmetic problems out loud in front of an audience (Kirschbaum et al., 
1993). In typical manipulations of the TSST, the audience is trained to not provide any feedback, 
and maintain only neutral facial expressions. The current study uses a TSST paradigm that aligns 
with previous work by Way and Taylor (2010), where there is an experimental, negative 
evaluative condition and control, neutral-feedback condition. The difference is that the audience 
in the negative evaluative condition are “judges” who are trained to provide negative verbal and 
nonverbal feedback while the participant performs each task (see Appendix A for a detailed 
behavioral script). Employing a control comparison condition facilitates the interpretation of 
condition effects on cortisol outcomes and is evident in our previous lab work (Avery & Vrshek-
Schallhorn, 2016). In sum, the TSST is a useful tool for dosing acute psychosocial stress and 
activating key stress response systems to evaluate patterns of dysregulation.  
Goals & Hypotheses 
The goal of the present study is to examine whether individual differences in HPA 
genetic variation, as examined using an MGPS from previously studied SNPs, predict cortisol 
and sAA reactivity to a stressful condition versus control condition in an emerging adult sample. 
Consistent with diathesis-stress theory, I hypothesize that an HPA MGPS will interact with stress 
condition (e.g., the negative evaluative condition of the TSST, as compared to a control 
condition) to predict cortisol response in an emerging adult sample. Specifically, higher HPA 
MGPS will predict relative blunting of cortisol reactivity in the negative evaluative versus 
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control condition (see Figure 1). Second, I hypothesize that a higher HPA MGPS interacts with 
condition to predict augmented sAA in the negative evaluative condition relative to the control 
condition (see Figure 2). Finally, I hypothesize that an HPA MGPS will interact with sAA 
reactivity and condition to predict cortisol reactivity, such that in the context of the negative 
evaluative stress condition, higher MGPS and sAA responses will predict blunted cortisol 
(Figure 3). 
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CHAPTER II: METHOD 
 
Participants 
The present sample includes non-depressed emerging adults (N = 144; 55% female; 18-
29 years) who were undergraduate students at the University of North Carolina at Greensboro. 
Individuals were recruited to participate in a study on genetics, lab-based stress, and stress 
responding. Participants were recruited from the psychology department’s “Mass Screening” 
procedure after filling out an eligibility questionnaire or were recruited through IRB-approved 
flyers posted on campus. Participants were invited to participate if they were between the ages of 
18-30, did not currently use any form of hormonal birth control, did not currently use nicotine, 
were not diagnosed with a chronic health condition, did not have a history of head trauma, were 
not taking steroidal or psychotropic medication, did not have a diagnosed learning disability, 
were not colorblind, and were not a non-native English speaker. Upon passing the initial 
screening, participants were screened for acceptable blood pressure. Participants with either a 
systolic blood pressure above 160 and/or a diastolic blood pressure above 100 (i.e., the 
diagnostic threshold for hypertension) were excluded as a safety precaution and to avoid 
confounding effects (Gu et al., 2008), as aims unrelated to the current study examined 
cardiovascular responses to stress. 
A total of 152 participants were consented and completed the full protocol. After 
excluding individuals for missing more than two SNPs (n = 5) and for outliers (n = 3), a total of 
144 participants were included final analyses. The average age was 19.5 years (SD = 1.94, range: 
18-29) and self-reported gender was 58.1% female and 41.9% male. Regarding race and 
ethnicity, participants reported identifying as: 44.4% Black/African American, 39.2% White, 
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4.7% Hispanic/Latino/a, 3.4% Asian/Pacific Islander, 2.7% Biracial, and 5.4% Other. See Table 
3 for the demographic composition of the sample. 
Materials and Measures 
Salivary DNA  
Participants provided saliva samples for DNA extraction and genotyping via passive 
drooling through a straw into sterile DNAse and RNAse-free, cryogenic vials. After collection, 
saliva samples were stored in a freezer at -80C. Frozen samples were shipped by courier to the 
University of Wisconsin Next Gen Core Lab for testing of 14 HPA genetic variants. DNA was 
extracted using Oragene extraction kits (DNA Genotek, Ontario, Canada).  
For quality control, all allele frequencies were tested for deviations from expected genotype 
frequencies, consistent with Hardy Weinberg Equilibrium (HWE). Deviations from HWE are 
represented by a significant chi square goodness of fit test and can indicate the potential for 
genotyping errors, but can also arise due to racial/ethnic sample admixture. If any variants or 
haplotypes deviated from HWE in the full sample, I checked for deviations within individual 
racial/ethnic groups because expected differences by group can lead to spurious failures of HWE 
in racially/ethnically heterogeneous samples. In the event that variants continued to deviate from 
HWE within racial/ethnic groups, I excluded the variants from primary analyses. 
Salivary Cortisol and α-Amylase (sAA) 
Saliva was collected at 5 points throughout the study: (1) at baseline (+0 min), (2) after 
the instructions for the TSST were provided (+5 from baseline), (3) after the TSST was 
completed (+20 min after baseline), (4) after completing several computerized cognitive tasks 
not discussed here (+45 min after baseline), and (5) after debriefing was completed (+65 min 
after baseline). A tube of saliva was collected through passive drooling through a straw and into 
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a sterile cryogenic vial. These tubes were also stored in -80C freezers, and then shipped to Trier, 
Germany for duplicate assay for cortisol and sAA at the conclusion of the study. I screened data 
for excessive outlying values (>M+/-3 SDs) in the combined sample for baseline samples, and 
within condition for remaining samples, and winsorized outliers to M+/- 3 SDs, which is 
customary for these biomarkers (Vrshek-Schallhorn et al., 2018).  
I examined reactivity in each biomarker by constructing Area Under the Curve with 
Respect to Increase (AUCi), which reflects reactivity over baseline levels, emphasizing change 
over time while incorporating multiple time points (Pruessner et al., 2003). Once I calculated 
AUCi values, I reassessed them for univariate outliers within condition. If AUCi values still 
exceeded >M+/-3 SDs, they were excluded from analyses. As a result, two cases of sAA 
reactivity in the negative evaluative condition were excluded from analyses, and one case in the 
control condition for cortisol reactivity was excluded from analyses. Positive values of AUCi 
reflect the predominance of an increase from baseline, whereas negative values the 
predominance of a decrease in levels from baseline. I used samples 1, 3, 4, and 5 to calculate 
cortisol AUCi, and samples 1, 2, 3, and 4, to calculate sAA AUCi due to well-established 
differences in the time-courses for their reactivity (Nater et al., 2007).  The second sample was a 
priori intended only to measure salivary alpha-amylase (sAA), following evidence of its rapid 
responding, and preliminary analyses show that sAA has returned to baseline on average by the 
4th sample, indicating that also using the 5th sample for sAA may distort the measure of 
reactivity.   
Socioeconomic Status 
Participants reported parental education and vocational attainment necessary to compute 
the Hollingshead Index, an indicator of socioeconomic status (SES; Hollingshead, 1975). Scores 
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range from 8 to 66, with higher scores reflecting a higher SES (M = 44.56, SD = 12.78). Because 
SES is associated with depression risk and has been shown to influence HPA axis activity 
(Hoebel et al., 2017), SES was centered and included as a covariate if the initial model without 
covariates was significant. 
Current and Lifetime MDD 
Participants were screened for current MDD with the gold-standard Structured Clinical 
Interview from the DSM-IV (SCID). Participants with current MDD were diverted to the control 
condition out of an abundance of caution and were excluded from analyses involving the TSST 
due to non-randomization. We did not want to put participants with depression at increased risk 
by completing a negative evaluative TSST, plus we believed it could confound results based on 
meta analytic evidence (Burke, Davis, et al., 2005). Lifetime MDD was measured for use in 
analyses beyond the scope of the present project, and those with a history of MDD (40.3% of 
sample) completed the study the same as those without such history (n = 58).  
Multilocus Genetic Profile Score 
The current study examined the largest, most comprehensive MGPS possible with the 
available data (14 SNPs). To do so, I calculated an MGPS using all previously reported SNPs 
that are not excessively correlated with one another (> 0.7) in preliminary examination. The 
genes and polymorphisms include: CRHR1 (rs110402, rs7209436, rs242924, rs4792887, 
rs242939, rs1876828); NR3C1 (rs41423247, rs10482605, rs10052957); NR3C2 (rs5522, 
rs2070951, rs4635799); and FKBP5 (rs1360780). There is evidence of four haplotypes (sets of 
polymorphisms that tend to be inherited together) in the current study. First, there is evidence of 
a three-SNP haplotype in the CRHR1 gene (rs242941, rs242939, rs1876828) forming a “GAG” 
haplotype (Pagliaccio et al., 2014; 2015a; 2015b). There is additional evidence of a protective 
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“CA” haplotype in the NR3C2 gene (rs5522 and rs2070951; Feurer et al., 2017), and an 
additional NR3C2 “CT” haplotype (rs5522 and rs4635799; Di Iorio et al., 2017). Feurer et al., 
(2017) and Di Iorio et al., (2017) both use the SNP rs5522 in their diverging NR3C2 haplotypes, 
and therefore cannot be examined in tandem as to not double count rs5522 in the variance. 
Instead, I used Feurer et al.’s haplotype using the rs2070951 SNP due to its extensive 
characterization in the literature (de Kloet et al., 2016; Klok et al., 2011; van Dijk et al., 2017), 
but results with Di Iorio et al. 2017’s haplotype are presented as well. Finally, a protective 
“TAT” haplotype in the CRHR1 gene (rs7209436, rs110402, and rs242924) is noted in previous 
work (Feurer et al., 2017). Haplotypes using multiple SNPs were treated as a single marker, 
consistent with prior work (Feurer et al., 2017; Pagliaccio et al., 2014; 2015a; 2015b).  
The coding of each variant is presented in Table 1. Across all polymorphisms, each 
genotype and haplotype were coded for the presence (2) or absence (0) of at-risk genotypes 
(indicating two or zero “risk” alleles), with 1 assigned to heterozygote “intermediate” cases if 
supported by biological evidence as used in prior reports (Bogdan et al., 2016; Starr & Huang, 
2019). Haplotypes that are protective, such as the CRHR1 haplotype used by Feurer et al., were 
coded as absence (2), intermediate as (1) and presence as (0). A score of summed 
polymorphisms for all 14 variants was calculated across each participant to create a MGPS 
(possible range of 0-16 after haplotypes are accounted for). Participants were included if missing 
up to 20% of genotypes per person based on previous MGPS work, and MGPS scores for those 
with missing SNP data were prorated by calculating their proportion of available risk variants 
(Vrshek-Schallhorn et al., 2015) by calculating the individual’s sum of available risk scores, 
divided by their maximum possible total score without the missing polymorphism (i.e., 7) to 
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achieve a proportion score, and returned to the scale of the MGPS via multiplication by 8. 
Individuals (n = 5) missing more than two genotypes were excluded from analyses.  
All genetic variants were assessed for Hardy-Weinberg equilibrium (HWE) using chi 
square tests. Chi square analyses revealed rs1360780 (FKBP5 gene) was not in HWE in the full 
sample (p < .0001 for rs1360780). Further, because racial/ethnic heterogeneity can explain some 
deviations from HWE, HWE was re-assessed within racial/ethnic groups using dichotomized 
minority status (0 = white, 1 = minority status). The SNP rs1360780 deviated from equilibrium 
within each group (white χ2  = 51.160, p < .0001; minority χ2   = 23.06, p < .0001). Because the 
variant rs1360780 deviated from HWE within both groups, it was excluded from analyses. The 
final HPA MGPS scores (excluding rs1360780) were normally distributed (M = 5.40, SD = 1.40, 
observed range: 1 - 10.5). One-way ANOVA analyses revealed no significant difference between 
HPA MGPS profiles across conditions (F (1,143) = 1.250, p = .265). 
Procedure 
Participants were quasi-randomized to either the control or TSST condition. Most 
participants signed up online blind to a pre-scheduled condition. A smaller proportion of 
participants scheduled their session directly with a study coordinator, who did not know the 
personal characteristics (e.g., HPA MGPS) of the participants when scheduling, and the 
participants were blind to their scheduled conditions. This study was comprised of two sessions, 
completed in two consecutive days in most instances. These sessions were completed between 
1:00 P.M. and 5:30 P.M. to reduce the influences of diurnal cortisol and sAA (Dickerson & 
Kemeny, 2004; Nater et al., 2007). Next, participants completed a semi-structured clinical 
interview about current depressive episodes, followed by a series of computerized questionnaires 
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on personality and life experiences. Participants completed an additional life stress interview and 
cognitive measures not discussed here for other aims in the larger study. 
In the second session, individuals first completed several computerized questionnaires to 
adjust to laboratory conditions, followed by either a negative-evaluative variant of the TSST 
(Way & Taylor, 2010) or a putatively non-stressful control protocol. A smaller group completed 
an experimental third intermediate condition as part of the larger project but did not provide 
DNA samples; they are not included in the present study. Saliva samples were collected at five 
time points during the TSST as previously noted. Participants either received course credit or 
$30 for study completion, and all participants received $5 as an incentive for an additional 
cognitive task not described here.   
Trier Social Stress Test (TSST) 
In both conditions, participants performed similar tasks, where they were told that they 
were being video-recorded and were instructed to face the camera. Participants were asked to 
choose a slip of paper out of a box that had ostensibly different topics. Unbeknownst to the 
participant, all participants in the negative evaluative condition had the same speech prompt, 
which was to talk about their electability for a student leadership position, including their people 
skills, organizational skills, intellectual abilities, and reliability. Participants in the control 
condition were asked to speak for 5 minutes on a neutral topic, tips others could use to maintain 
a healthy lifestyle. Participants were given 5 minutes to prepare the speech and were asked to 
deliver the speech for 5 minutes. Afterwards, participants completed an arithmetic task counting 
backwards from 2,017 by 13’s for 5 minutes. When participants made a mistake, they were asked 
to start again in both conditions.  
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In the negative evaluative condition, participants were told that they would be evaluated, 
and were uniformly provided negative nonverbal feedback by two trained judges. Judges in the 
negative condition were one male and one female research assistant who followed behavioral 
scripts to convey boredom and dissatisfaction with the speech (e.g., exchanging a judgmental 
glance with each other; behavioral script located in Appendix A). In addition, judges reminded 
participants to look at the camera, demanded participants continue speaking for the entire 5-
minute period, or told them to go faster in the arithmetic portion, in efforts to provide stern 
feedback. In contrast, in the control condition, there were no confederate judges, the participants 
were explicitly told they would not be evaluated, and the experimenter remained in the room 
pretending to prepare for future sessions, but out of the participant’s direct line of sight. 
Similarly, the experimenter was polite, but provided neither positive nor negative feedback. In 
the arithmetic portion, control participants were provided neutral feedback when a mistake was 
made and were asked pleasantly to start over to ensure similarity of tasks across conditions. 
These experimental conditions produced expected differences in cortisol reactivity in previous 
studies (Avery & Vrshek-Schallhorn, 2016; Ditcheva et al., 2018; Vrshek-Schallhorn et al., 
2019).  
Debriefing.  Participants were fully debriefed after the TSST. Specifically, participants 
assigned to the experimental (negative-evaluative) condition of the TSST were told that the panel 
were research assistants trained to provide negative, non-verbal feedback to all participants and 
showing the participant the behavioral script. Participants were further told that the panel was 
trained to make the participant feel like they were doing a bad job, and that the feedback they 
gave had nothing to do with the participant’s performance on the task. Last, the participants in 
the experimental condition were told that that they were not actually evaluated, and all were told 
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that no one was videotaped in either condition. All participants were told the general purpose of 
the study and could ask any remaining questions. Finally, participants provided documentation of 
debriefing and continued informed consent to use their data due to the prior deception; no 
participants withdrew their data at this time. 
Manipulation Checks 
Self-Report 
After completing the TSST, participants completed several manipulation checks. They 
were asked to what extent they felt evaluated, and if they had felt evaluated, to what extent the 
evaluation was positive and negative on an online questionnaire administered through Qualtrics. 
I used this information to test whether conditions differed in perceived evaluation using separate 
one-way ANOVAs, where individuals in the experimental condition of the TSST are predicted to 
show increased feelings of overall evaluation and negative evaluation, but less positive 
evaluation, compared to individuals in the control condition.   
Cortisol & α-Amylase 
Cortisol and sAA reactivity as AUCi were used as an additional manipulation check. 
Consistent with analytic procedures in the stress literature, I calculated cortisol and sAA area 
under the curve with respect to increase (AUCi; Pruessner et al., 2003), which calculates cortisol 
and sAA reactivity, compared to their respective baseline levels. I compared cortisol and sAA 
levels in experimental versus control groups as a manipulation check. A single value was 
produced for cortisol and sAA respectively and entered in as dependent variables in separate 
one-way ANOVA models.   
Cortisol and sAA were analyzed AUCi to capture reactivity, or change over time. As 
stated earlier, values >M+/- 3 SDs were winsorized to the value of the third SD value. A total of 
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n = 1 value was winsorized for cortisol. There were not any sAA values considered to be outliers 
per these guidelines. Participants in the current sample obtained cortisol reactivity AUCi scores 
that were normally distributed (skewness = .923, kurtosis = 1.246). Scores for sAA AUCi were 




I present descriptive statistics of key study variables, including demographics (e.g., age, 
gender, SES), HPA MGPS and sAA distribution across the sample, as well as the number of 
participants in each TSST condition. Second, I present zero-order bivariate correlations among 
independent variables (HPA MGPS, sAA, TSST condition), covariates (e.g., gender, SES, 
race/ethnicity), and the dependent variable of cortisol. Conditions were tested for differences in 
gender, SES, and baseline biomarker levels. I initially ran primary analyses in the full sample 
comprising of all racial/ethnic groups (dummy coding minority stats, non-minority status as 0/1). 
If models showed a significant effect, I reran the finding in the largest homogeneous racial/ethnic 
subgroup of participants to examine population stratification, or the differences in allele 
frequencies between racial groups, which may produce spurious findings if left unchecked. 
Moreover, prior work has identified differences in this HPA MGPS by race/ethnicity (Starr & 
Huang, 2019). All primary models were examined for multivariate outliers using Cook’s 
distance; I re-analyzed models without individuals scoring >.5 on Cook’s distance to gauge 
influence on results as needed (re-including them if they do not influence results, and excluding 
them if they do influence results) and automatically excluded individuals scoring >1.0 on Cook’s 
distance from models. After inspecting these values, I excluded no cases from analyses.   
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Covariates 
To ensure that any significant GxE effects are not spuriously arising due to other 
variables that influence HPA axis and SNS activity, I first examined whether experimental 
groups differ by sex, race/ethnicity, and SES. I followed up all significant GxE models (initially 
conducted without covariates) by adding any variables that differ by condition. Consistent with 
previous work in GxE research, I covaried not only main effects of the covariates, but also 
interactions with the HPA MGPS and condition separately (e.g., Covariate x Condition), to 
partial these covariate effects from the GxE interaction effect (Keller, 2014). I ran models with 
and without these covariates to preserve power. 
Predicting Cortisol and sAA Reactivity 
Multiple linear regressions were used to test hypotheses with IBM SPSS v26 (IBM Corp, 
2019). Models for predicting cortisol and sAA reactivity were run separately, with cortisol AUCi 
and sAA AUCi entered as the dependent variables. Next, for main effects, I entered HPA MGPS 
in the model, as well as TSST stress condition, which was dummy coded (0 = control, 1 = 
challenge). Then, I created a product term of condition and centered HPA MGPS and entered it 
in a second block. To test the third hypothesis, I entered main effects in the first block, followed 
by all relevant two-way interactions in the second block, and the three-way interaction of 
Condition x HPA MGPS x sAA Reactivity in the final block. For all significant models, I 
followed up by rerunning models with relevant covariates. If the effect remained, I then 
decomposed effects using regions of significance analyses using the Johnson-Neyman technique 
(Johnson & Fay, 1950) which permits probe the boundaries of significant values contributing to 
the interaction effect (Preacher et al., 2006).  Finally, consistent with other work with MGPS 
(Starr & Huang, 2019), I ran post-hoc models with individual SNPs rather than the MGPS to 
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examine whether the HPA MGPS effect was driven by multiple, significant SNPs or the 
cumulative effect of the HPA MGPS. 
Power Considerations 
This is the first investigation in which an HPA MGPS is being used to predict cortisol or 
sAA reactivity in an adult sample, thus effect sizes are not thoroughly established. However, 
among a sample of emerging adults (N = 112), there was a significant interaction between a 
single genetic variant and life stress in predicting cortisol reactivity (Avery & Vrshek-
Schallhorn, 2016). The sample size (N = 144) is somewhat larger than typical for studies of the 
TSST (meta-analytic mean N = 29.58; Dickerson & Kemeny, 2004); however, this level was 
selected to achieve greater power for genetic analyses, which we assumed would have the lowest 
power (Avery & Vrshek-Schallhorn, 2016), and to achieve similar size as other stress-induction 
studies involving genetics published when this study was being designed (e.g., N = 118, Way & 
Taylor, 2010). Given the sample size of the current study (N = 144), adequate power is expected. 
Moreover, sensitivity analyses for multiple linear regression for the two-way interactions with 3 
predictors: 1) HPA MGPS, 2) Condition, and 3) Condition x HPA MGPS powered to .80 
indicated a minimum detectable effect size of 0.0752 (R2 deviation from zero) with alpha levels 








 There were no group (control vs. challenge condition) differences based on gender (F 
(1,142) = .000, p = 1.000) or minority status (F (1,142) =, p = .236). However, there were group 
differences based on SES (F (1,142) = 1.002, p = .026), such that the experimental group (M = 
42.198, SD = 13.412) had a lower SES relative to the control group (M = 46.926, SD = 11.738). 
SES was a planned covariate, however, which addressed this potential confound. See Table 4 for 
all sample characteristics across TSST condition.  
Manipulation Checks 
Manipulation checks were completed to ensure that the TSST conditions had the 
expected effect on perceived evaluation, cortisol reactivity, and sAA reactivity. 
Validity of TSST Stress Paradigm. As expected, one-way ANOVAs revealed 
significant differences across condition of overall perceived evaluation (F (1,143) = 14.429, p < 
.001), positive evaluation (F (1,127) = 38.131, p < .001), and negative evaluation (F (1,146) = 
52.978, p < .001), such that the negative evaluative condition reported greater overall perceived 
evaluation, less perceived positive evaluation, and greater perceived negative evaluation (Table 
5).  
Biomarker Reactivity. One-way ANOVAs revealed significant differences across 
condition for cortisol AUCi (F (1,142) = 43.752, p < .001) and sAA AUCi (F (1,146) = 6.267, p 
= .013). Specifically, sAA was increased in the challenge condition (M = 9.948, SD = 14.344) 
compared to the control condition (M = 3.990, SD = 14.508), demonstrating an increase of sAA 
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over time from baseline. Similarly, cortisol was significantly increased in the challenge condition 
(M = 18.658, SD = 14.344) compared to the control condition where there was an observed 
decrease of cortisol level from baseline consistent with cortisol’s natural diurnal rhythm (M = -
11.375, SD = 30.711).  A visualization of cortisol activity across TSST condition is presented in 
Figure 4. There were no significant differences in baseline cortisol (F (1,143) = .664, p = .416) or 
sAA levels (F (1,143) = .388, p =.535) across condition. A visualization of sAA activity across 
TSST condition is presented in Figure 5. 
Zero-order Correlations 
 Zero-order bivariate correlations were examined among focal predictors, covariates, and 
dependent variables and are presented in Table 6.  
Primary Regression Results 
Interaction Effects of MGPS x TSST Condition Predicting Cortisol Reactivity 
 Results from regression models indicated an HPA MGPS did not significantly moderate 
the relationship between TSST condition and cortisol reactivity (interaction term t = .229, p = 
.819). A main effect emerged in TSST condition predicting cortisol reactivity as expected (t = 
6.304, p < .001). No other main effects emerged. Results for this model are presented in Table 7 
and a visualization of cortisol reactivity (AUCi) as a function of HPA MGPS and stress 
condition is presented in Figure 6. 
Interaction Effects of MGPS x TSST Condition Predicting sAA Reactivity 
 Results from regression models revealed that an HPA MGPS not significantly moderate 
the relationship between TSST condition and sAA (t = -.757, p = .450). A main effect emerged 
in TSST condition predicting sAA reactivity as expected (t = 2.322, p = .021). No other main 
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effects emerged. Results are presented in Table 8, and a visualization of sAA reactivity (AUCi) 
as a function of HPA MGPS and stress condition is presented in Figure 7. 
Interaction Effects of MGPS x TSST Condition x sAA Predicting Cortisol Reactivity 
 Regression models revealed significant evidence that the relationship between TSST 
condition and cortisol reactivity depended jointly on a 7-SNP HPA MGPS and sAA reactivity (t 
= 2.294, p = .023; R2 = .0285), a three-way interaction effect. Additionally, there was a main 
effect such that TSST condition predicted cortisol reactivity as expected (t = 6.156, p < .001). 
See Table 9 for results of this model. Because groups did not differ based on gender or 
race/minority status, I included only SES as a covariate in the follow-up model. Once accounting 
for SES and its interactions with sAA, MGPS, and condition (consistent with Keller, 2014), 
results for the hypothesized 3-way interaction remained significant (t = 2.462, p = .015). In 
addition to a significant main effect of condition (t = 6.035, p < .001), SES and MGPS interacted 
to predict cortisol reactivity (t = -2.438, p = .016). See Table 10 for results.  
For post-hoc analyses of the hypothesized effect, I utilized the Johnson-Neyman 
technique (Johnson & Fay, 1950) using SPSS PROCESS (Hayes, 2013) to probe regions of 
significance (ROS) identifying at which levels of genetic risk and sAA reactivity TSST condition 
significantly predicted cortisol reactivity. However, critical to interpretation, we are most 
interested in the regions in which condition does not result in a significant difference in cortisol 
reactivity, consistent with blunting in response to the negative evaluative challenge condition. 
This resulted in two ROS at low sAA reactivity, at ≤ -2706.63 U/ml (slightly below -1 SD from 
the mean) and separately at high values of sAA reactivity, ≥ 3059.21 U/ml (slightly below +1 SD 
above the mean). Thus, the regions that did not significantly differ, and could be viewed as 
relatively blunted were defined by the region -2706.63 to 3059.20 U/ml. To visualize results, 
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cortisol reactivity was plotted as a function of HPA MGPS on the X axis across three panels 
representing low (-1 SD), middle (mean), and high (+1 SD) sAA reactivity (Figure 8). An 
alternative visualization depicts cortisol reactivity as a function of four profiles (high sAA with 
high and low MGPS, low sAA with high and low MGPS) in Figure 9. 
We also reran this finding in the largest homogenous racial/ethnic group, consistent with 
approaches with heterogenous samples in GxE interaction research (Starr & Huang, 2019). The 
largest homogenous group in our sample was Black and African American participants (44.4%). 
Given the reduced sample size in this analysis (n = 64), we did not focus on p-values and instead 
evaluated the magnitude of the beta coefficient and direction. Results were similar to those in the 
full sample such that the sAA x Condition x MGPS interaction term approached significance in 
predicting cortisol (b = .037, p = .088), which was similar to the magnitude of the beta 
coefficient and direction in the full sample (b = .027, p = .023). Moreover, because there were no 
other significant correlations or group differences between race/ethnicity and key outcomes 
(sAA, cortisol), we conclude that it is unlikely that population stratification influenced findings. 
Finally, consistent with other work with MGPS (Starr & Huang, 2019), we ran post-hoc 
SNP x TSST x sAA predicting sAA to examine whether the HPA MGPS effect was driven by 
multiple, significant SNPs, rather than the cumulative effect of the HPA MGPS. Results indicate 
that only one SNP (rs4792887) was significant (t = 2.182, p = .031; all other p’s > .05), and also 
revealed that SNPs had effects in opposite directions, suggesting that the effect of the HPA 
MGPS is driven by the additive, cumulative effect of several of the HPA MGPS, but that others 
tended to reduce the detected additive effect. Results are presented in Table 11. 
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Tests with Previously Established HPA MGPS 
Each of the following previously established HPA MGPS were directly tested in the 
current study, without FKBP5 as noted previously. This includes the HPA MGPS reported in 1) 
Starr & Huang, 2019, Pagliaccio et al., 2014, 2015a, and 2015b, 2) Feurer et al., 2017, and 3) and 
Di Iorio et al. 2017.  
None of these previously established HPA MGPS moderated the relationship between 
TSST condition and cortisol reactivity (all p’s > .05) or sAA reactivity (all p’s > .05). See Tables 
12 and 13 for results of models using Pagliaccio et al., (2014, 2015a, 2015b), and Starr & Huang 
(2019)’s 10-SNP MGPS predicting cortisol reactivity and sAA reactivity, respectively. See 
Tables 14 and 15 for results of models using Feurer et al., (2017)’s 3-SNP model predicting 
cortisol reactivity and sAA reactivity, respectively.  See Tables 16 and 17 for results of models 
using Di Iorio’s 6-SNP HPA MGPS predicting cortisol reactivity and sAA reactivity, 
respectively. 
Protective Haplotype x TSST Condition Predicting Cortisol and sAA Reactivity 
 An additive score of the CRHR1 “TAT” haplotype and NR3C2 “CA” haplotype did not 
moderate the relationship between TSST condition and cortisol reactivity (t = -.791, p = .430), 
nor between TSST condition and sAA reactivity (t = -1.300, p =.196). See Tables 18 and 19 for 
results of these models. 
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CHAPTER IV: DISCUSSION 
 
The current study utilized a GxE interaction framework to examine whether an additive 
genetic risk score influenced acute physiological reactivity to a negative-evaluative stressor 
versus a control in a healthy, emerging adult sample. Outcomes were measured using a multi-
system approach, collecting both cortisol and sAA reactivity to index HPA Axis and SNS 
activity, respectively. Contrary to predictions, the current study demonstrated that the 
relationship between a lab-induced stressor (TSST condition) and either cortisol or sAA 
reactivity did not significantly depend on an additive score of genetic variants known to impact 
the HPA axis. However, the results of the proposed three-way interaction demonstrated that the 
relationship between TSST condition and cortisol reactivity depended on both an HPA MGPS 
and sAA reactivity, implicating joint vulnerability across two stress systems as a risk factor for 
dysregulated stress responding. First, I present the conceptualization and theoretical 
considerations underpinning the relationship between stress exposure, sAA, and MGPS and 
cortisol reactivity and implications.  Following, I discuss methodological, developmental, and 
theoretical considerations that may partially explain the null findings of the first two primary 
hypotheses and unsuccessful extensions of prior MGPS.  
Three-way Interaction of sAA, HPA MGPS, and Condition Predicting Cortisol Reactivity  
The current study is the first to report a significant three-way interaction such that sAA 
(as an index of SNS activity under threat) and an HPA MGPS moderate the relationship between 
stress exposure and cortisol reactivity. Findings partially supported study hypotheses. Consistent 
with hypotheses, the difference between cortisol levels across conditions was most pronounced 
in those with both low sAA and low HPA MGPS. Additionally, consistent with predictions, there 
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were moderate levels of cortisol reactivity in the negative evaluative condition for low sAA and 
high HPA MGPS—and as such, under low sAA, higher MGPS corresponded to comparatively 
blunted cortisol reactivity. However, in contrast to study hypotheses, individuals with high sAA 
and high MGPS had pronounced cortisol elevation in the negative evaluative condition, rather 
than the hypothesized blunted effect, and those with high sAA and low MGPS showed relative 
blunting as opposed to hypothesized moderate reactivity. 
 That an HPA MGPS differentially predicted cortisol reactivity as function of sAA 
reactivity is complex and intriguing. We posit that rather than an HPA MGPS capturing “risk” 
exclusively for negative outcomes, that instead, it reflects a sensitivity score, and appears to be 
sensitive to SNS influence in modulating cortisol.  Conditions of low sAA reactivity 
demonstrated that a higher MGPS was associated with relative cortisol blunting. However, under 
higher sAA, HPA MGPS may indicate level of sensitivity to higher SNS activation. Greater 
sensitivity may lead to greater coordination and symmetry between sAA and cortisol responses. 
Thus, when sAA is high indicating robust SNS inputs, low MGPS (i.e., less sensitivity, in this 
view) was associated with low cortisol reactivity to stress (an uncoordinated response), while 
high MGPS (i.e., more sensitivity, in this view) was associated with high cortisol reactivity to 
stress (a more coordinated, symmetrical response). Although speculative, this sensitivity may be 
more important when sAA reactivity is high (where initial predictions were not supported), as 
opposed to when it is low (where initial predictions were supported).  
Cortisol is conceptualized as a resource-mobilizing hormone to activate physiological and 
psychological processes that aid in adaptive responses to threat (Sapolsky et al., 2000). By this 
logic, a high sAA and high MGPS may suggest symmetric, coordinated effects between the HPA 
axis and SNS to respond to threat.  By contrast, when SNS activity is high but HPA MGPS is 
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low, it would follow that the individual has less sensitivity to SNS activity via reduced genetic 
variation and thereby produces a less robust cortisol response toward the direction of blunting. 
Blunted, or reduced responses have been conceptualized as a failure to mobilize resources in 
response to threat, or a “giving up” response which has been linked to depression risk (Morris et 
al., 2014; Vrshek-Schallhorn et al., 2018), perhaps hinting that an asymmetrical (low sAA/high 
MGPS; high sAA/low MGPS) may be less adaptive by producing less resource-mobilizing 
cortisol. 
It is prudent to acknowledge that this conceptualization of an HPA MGPS as potentially 
adaptive at high or low values does not align with the initially hypothesized diathesis stress 
framework. If the HPA MGPS is the theorized diathesis, we would have expected to see an 
increased HPA MGPS predict blunted cortisol. Here, however, we observe that HPA MGPS can 
be associated with both blunted and elevated cortisol responses, as a function of sAA reactivity. 
The conceptualization of an HPA MGPS as not solely risky adds to the pool of mixed results, in 
which some studies finding that a higher HPA MGPS moderates environmental risk and confers 
increased clinical/endophenotypic profiles consistent with depression (Di Iorio et al., 2017; 
Pagliaccio et al., 2014; 2015a; 2015b), while others have suggested the HPA MGPS acts as a 
plastic, or malleable score (Feurer et al., 2017; McKenna et al., 2021; Starr & Huang, 2019) 
consistent with sensitivity rather than risk per se. For example, McKenna, Hammen, and 
Brennan (2020) recently tested a 3-SNP HPA MGPS and maternal prenatal perceived stress 
(self-report measure) in offspring predicting depression in a longitudinal design. Individuals who 
had a higher HPA MGPS reported significantly higher depressive symptoms in the context of 
maternal prenatal stress at age 20, but fewer depressive symptoms in the context of lower 
maternal prenatal stress. While sympathetic activity was not concurrently measured in McKenna 
 41 
et al., (2020), it conveys an important idea that an HPA MGPS may not function solely as a risk 
score, but as a malleability score. The current study adds to this literature an additional potential 
mechanism by which an HPA MGPS score influences stress reactivity, linking it to the SNS 
system, though replication is also an important next step. 
Additionally, results indicated that SES and MGPS interacted to predict cortisol reactivity 
such that high SES participants (+ 1 SD from the mean) with high MGPS had low/blunted 
cortisol levels. By contrast, low SES participants (- 1 SD from the mean) with a high MGPS had 
a high cortisol response. This did not vary as a function of stress level. No prior studies have 
examined SES in concert with MGPS and cortisol reactivity, and this work suggests an HPA 
MGPS may be sensitive to SES, though requires further examination. 
HPA MGPS and Condition Failing to Predict Cortisol. 
In contrast to previously published studies of HPA MGPS, the current study found that 
the relationship between negative evaluative threat exposure and cortisol did not significantly 
depend on an HPA MGPS alone in an emerging adult sample. Possible explanations for this 
pattern of findings may include: 1) use of heterogenous stressors in prior work (naturalistic 
versus lab-based), 2) stressor severity (chronic versus acute), and 3) developmental 
considerations.  
Methodological Considerations 
The current study found that an acute, explicit negative evaluative lab-based stressor did 
not moderate the relationship between an HPA MGPS and cortisol reactivity, both in the full 
MGPS as well as the additive protective haplotype score. To my knowledge, this was the first 
experiment that utilized any variant of the TSST protocol as the “E” of a GxE interaction 
framework with an HPA MGPS predicting cortisol reactivity in an emerging adult sample. One 
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prior study examined children’s cortisol reactivity to a series of fun and frustrating tasks intended 
to evoke positive and negative affect (Pagliaccio et al., 2014), but no studies have examined 
more traditional lab-based psychosocial stress inductions such as the present explicit negative 
evaluative induction. Across all remaining previous studies of an HPA MGPS, participants (or 
their parents depending on age) were administered semi-structured interviews ascertaining 
information about adversity in the child/adolescent’s life, almost exclusively naturalistic 
stressors.  The current study extends this work by being the only to test the TSST and only one of 
two studies to use the HPA MGPS to examine cortisol reactivity.  
This raises the question whether stressor duration (acute versus chronic) or stressor type 
(interpersonal versus non-interpersonal), might influence whether a significant GxE effect 
emerges with an HPA MGPS. Prior studies have found evidence that the HPA MGPS interacts 
with both chronic (Starr & Huang, 2019), and episodic (acute) stressors (Feurer et al., 2017; 
Huang & Starr, 2019; Starr & Huang, 2019). Interestingly, Starr & Huang (2019) demonstrated 
that an HPA MGPS moderated the relationship between acute and chronic, interpersonal stress 
on depressive symptoms, such that those with higher MGPS and increased stress exposure had 
increased depressive symptoms. By contrast, an HPA MGPS did not interact with non-
interpersonal stress to predict depressive symptoms in the full sample. This is consistent with 
abundant research that emphasizes that interpersonal stress, such as stress that affects an 
individuals’ close relationships, or availability of interpersonal relationships, is a key 
determinant by which stressors can lead to depression (Hammen, 2005). 
Despite the ability of the present study’s negative evaluative variant of the TSST to 
robustly induce psychosocial threat, one possibility is that the TSST may not sufficiently mimic 
naturalistic interpersonal stress, which appears to have been a critical aspect of several prior 
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such GxE studies. The current study adds to a growing conversation around the critical 
importance of delineating and testing “candidate environments” for GxE research (Dick et al., 
2015; Starr et al., 2019). Specifically, previous groups have underscored that the specification of 
a candidate environment is equally as important as specifying gene candidates (Vrshek-
Schallhorn et al., 2014), and further, that it is possible that different types of stress are relevant 
for different types of genetic variables (Dick et al., 2015). The current study extends this concept 
by documenting a lack of significant support that the HPA MGPS alone modulates cortisol and 
sAA responses to negative evaluative lab-based stress.  
Developmental Considerations 
Further, the current study is one of the few that examined an HPA MGPS in an emerging 
adult sample. The remaining studies were completed in samples of children (Feurer et al., 2017 
and Pagliaccio et al., 2014, 2015a, 2015b) and adolescents (Huang & Starr, 2020; Starr, Dienes 
et al., 2019; Starr & Huang, 2019). Importantly, the impact of stress exposures on stress 
reactivity varies as a function of developmental stage (Crosswell & Lockwood, 2020). 
Specifically, childhood (i.e., prior to age five), puberty, and adolescence are considered sensitive 
periods for stress exposure, where prior evidence indicates that stress exposures during these 
periods can sensitize the HPA axis leading to lasting changes in reactivity (Christine Heim et al., 
2008; Lupien et al., 2009). This is in part due to brain areas key to HPA axis regulation (e.g., 
prefrontal cortex, an area rich in primary cortisol receptors) not being fully developed (Crosswell 
& Lockwood, 2020; Lupien et al., 2009), leading to sensitization of the HPA axis (C. Heim et al., 
2000). Additional evidence consistent with this notion comes from the only other study to our 
knowledge that examined the effect of an HPA MGPS on cortisol reactivity (Pagliaccio et al., 
2014).  Specifically, children with and without histories of early-life stress were exposed to a 
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lab-based task and provided salivary cortisol at baseline, before, and after the task. The authors 
observed a positive main effect of an HPA MGPS predicting augmented cortisol reactivity in 
children with a history of ELS. Considering developmental theories of stress sensitivity coupled 
with Pagliaccio et al.’s (2014) findings, this suggests that emerging adulthood may be 
considerably less sensitive to stress exposure relative to childhood and adolescence due to more 
developed stress-related brain structures, which could perhaps minimize the influence of the 
HPA MGPS.  
Taken together, methodological considerations, namely the candidate environment used, 
as well as developmental considerations may have contributed to a lack of evidence that the HPA 
MGPS moderates the effect of negative evaluative stress versus a control on cortisol reactivity. 
HPA MGPS and Condition Failing to Predict sAA Reactivity 
Despite theoretical and empirical evidence of physiological interconnectedness between 
SNS and HPA axis activity, the current study did not find evidence that an HPA MGPS and 
condition interacted to predict sAA reactivity. First, we mention other work that as examined 
HPA genetic variation in SNS outcomes. Next, we consider how sAA may be upstream of the 
HPA axis, and therefore be too distal of an outcome from the HPA MGPS as a potential 
explanation for null findings. 
Methodological Considerations 
Only one study to the best of our knowledge has examined HPA axis genetic variation 
predicting SNS-related outcomes. DeRijk et al., (2006) found that rs5522 (which affects 
mineralocorticoid receptors [MR]) interacted with TSST condition to predict ANS activity 
(measured through heart rate), such that individuals with two copies of this SNP had elevated 
heart rate. This study proposed that MR’s role in mediating fast membrane events in the brain 
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may elevate ANS activity. Beyond this, no prior work provides evidence of single or additive 
genetic HPA axis scores predicting SNS activity in the context of stress.  The current study 
informs future genetic work as it concerns examining the effect of HPA axis genetic variation 
predicting SNS outcomes. 
We predicted sAA as an outcome of the interaction of HPA MGPS and TSST condition. 
This was grounded in research demonstrating bidirectional influence of the HPA axis on SNS 
activity in response to the TSST (Andrews, D’Aguiar, & Pruessner, 2012, Andrews & Pruessner, 
2013) as well as salivary bioscience methodology (Granger & Taylor, 2020).  The theorized 
mechanism was that an HPA MGPS would affect the brain regions involved in the stress 
response (hypothalamus, paraventricular nucleus, hippocampus), affect cortisol, influence 
subsequent SNS activity, which would be reflected in sAA (not only HPA reactivity). Prior 
evidence contends that HPA axis mediation of sympathetic activity may unfold slowly (Sapolsky 
et al., 2000). It is possible that sAA as an outcome in this model may have been too distal from 
the mechanism of the HPA MGPS, and that the current study was able to capture sAA’s 
modulation of HPA MGPS activity, rather than vice versa.  
Limitations 
While the study benefited from strengths such as using a robust lab-based stressor, a 
novel genetic approach, and multisystem biomarkers to objectively capture stress reactivity, 
there were also limitations. First, the FKBP5 variant, rs1360780, deviated from HWE both in the 
full sample, and within each racial subgroup (white vs. minority status), and thus was not usable, 
which may have reduced the effect size and predictive ability of the MGPS. Moreover, the 
current study used previously established MGPS profiles for the purpose of facilitating future 
meta-analysis. However, it does not include all SNPs that have been found to influence HPA axis 
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reactivity (e.g., Arginine Vasopressin, Angiotensin Converting Enzyme genes; Normann & 
Buttenschøn, 2019); additionally, previously studied HPA MGPS profiles published after the 
present study’s genotyping was conducted, utilized different SNPs of the same genes (e.g., 
rs6198 of NR3C1; McKenna, Hammen, & Brennan, 2020), thus no extant HPA MGPS is 
exhaustive. Finally, as the use of sAA as a marker of SNS activity is relatively new, it would 
have benefitted the study to have concurrent measures of gold standard SNS activity (plasma 
catecholamines) to concurrently examine SNS activity in response to stress exposure.  
Future Research & Considerations 
As studies continue examining additive genetic profiles in GxE interaction frameworks, 
careful attention must be applied to both the “G” and the “E”. While the HPA MGPS profiles 
used in the current study all had roughly the same SNPs, variation in numbers of SNPs were used 
as well as variable inclusion of haplotypes. Research groups may have different criteria by which 
they qualify a SNP for inclusion in an MGPS (e.g., the SNP was found to predict intermediate 
and/or clinical outcomes), or may include several different SNPs of the same gene despite 
attempting to predict similar outcomes. Zhang and Belsky (2020) discuss the critical point of 
standardizing how SNPs are included in additive genetic scores, and being clear the extent to 
which they should be based on hypotheses grounded in biologically-plausible systems, versus 
from a genome-wide-association study which are atheoretical and hypothesis-free. By the same 
token, rigorous, judicious measuring of the environment through adoption of gold-standard, 
interview-based tools, parsing out acute versus chronic, interpersonal versus non-interpersonal, 




Scientists have long sought to identify risk factors that clarify who is most at risk for 
psychopathology following a stressful life event, to attenuate the burden of stress-related 
disorders, like depression. The current study was the first to demonstrate that the effect of an 
additive genetic profile related to the HPA interacted with SNS reactivity to predict an 
intermediate outcome related to depression, cortisol reactivity in response to negative evaluative 
threat, but did not provide support that this genetic score alone predicted cortisol or SNS 
reactivity to negative evaluative threat. This advances the effort to characterize the individual 
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APPENDIX A: TABLES AND FIGURES 
Table 1. Single Nucleotide Polymorphism Coding and Prevalence for Current Sample 
Gene Polymorphism Coding N Polymorphism Score  
0  1 2 
CRHR1 rs4792887 TT = 2, CT = 1, CC = 0 142 81 53 8 
CRHR1* 
TAT haplotype 
rs110402 Zero copies = 2 
One copy = 1 
Two copies = 0 





rs242941 Zero copies = 2 
One copy = 1 
Two copies = 0 





rs5522 Zero copies = 2 
One copy = 1 
Two copies = 0 




rs4635799 Zero copies = 0 
One copy = 1 
Two copies = 2 




rs41423247 GG = 2, CG = 1, CC = 0 142 12 61 69 
rs10482605 TT = 2, CT = 1, CC = 0 139 3 31 105 
rs10052957 AA = 2, AG = 1, GG = 0 133 60 64 9 
**FKBP5 rs1360780 TT = 2, CT = 1, CC = 0 135 122 5 8 













Table 2. Composition of HPA MGPS Across Previous Studies 
 
1Part of “GAG” haplotype CRHR1 gene (rs242941, rs242939, rs1876828) used by Pagliaccio et al., 2014; 2015a; 2015b. Of note, 
these SNPs were tested both independently and as part of the haplotype. 
2Part of “TAT” haplotype CRHR1 gene (rs7209436, rs110402, and rs242924) used by Feurer et al., 2017 
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Table 3. Sample Demographics Across Condition 
 * There were (n = 72) participants in the control condition, and (n = 72) in the challenge. 
 
Table 4. Sample Characteristics Across TSST Condition 
      Control Negative Evaluative 
                       Mean (SD) 
Age 19.47 (1.78) 19.40 (2.13) 
SES Index* 46.93 (11.74) 42.20 (13.41) 
HPA MGPS (range 0-16) 6.16 (1.46) 5.88 (1.62) 
Baseline Cortisol 5.40 (2.91) 5.01 (2.74) 
Baseline sAA 113.03 (60.85) 120.69 (84.97) 
sAA AUCi* 613.64 (1831.10) 1406.13 (2157.97) 
Cortisol AUCi*** -49.05 (121.48) 131.31 (208.75) 
*p < .05 
***p < .001 
   
 
  
Demographics (N = 144) N (%) 
Gender (Female) 82 (56.9) 
Race/Ethnicity  
     Black or African American 64 (44.4) 
     White 57 (39.6) 
     Latino/a 7 (4.9) 
     Asian/Pacific Islander 4 (2.8) 
     Biracial 8 (5.6) 
     Other 4 (2.8) 
TSST Condition*                            72 (50) 
 M (SD) 
Age 
SES index    
HPA MGPS 
sAA AUCi (U/ml) 
Cortisol AUCi (nmol/l) 
                        19.44 (1.96) 
                         44.56 (12.78) 
                         6.02 (1.54) 
                         1009.88 (2033.47) 
                         41.13 (192.75) 
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Table 5. Manipulation Checks for Primary Variables Across Conditions 





Perceived Evaluation 3.10 (1.07) 3.00(1.07)   F (1,143) = 15.921*** 
Positive Evaluation 3.39 (.61) 3.05 (.74)   F (1,143) = 40.842*** 
Negative Evaluation 1.27 (.45) 1.22 (.42)   F (1,143) = 52.127*** 
sAA AUCi 613.64 (1831.10) 1406.13 (2157.97)    F (1,143) = 5.6460* 
Cortisol AUCi -49.05 (121.48) 131.31 (208.75)    F (1,143) = 40.149*** 
* p < .05 
*** p < .001 
 
Table 6. Zero-Order Correlations Among Key Study Predictors, Covariates, and Outcomes 
aEthnicity is dummy-coded (0 = White, 1 = Minority status) 
bMeasured in AUCi 
*Correlation is significant at p < .05 
**Correlation is significant at p < .01 
 
Table 3. Primary Model 1: MGPS x Condition Predicting Cortisol Reactivity 
 
b SE(b) t-value p-value 
Intercept -49.744 33.759 -2.323 .022 
TSST Condition 181.378 29.696 6.304 <.001 
MGPS (centered) 1.405 14.304 .100 .920 
MGPS x Condition 4.316 18.988 .229 .819 
Note. Bolded values indicate p < .05. 
 
  
 1 2 3 4 5 6 7 
1. Ethnicitya   -       
2. Gender  .18*  -      
3. SES  -.20*  .08 -     
4. TSST  -.02  .00 -.19* -    
5. HPA MGPS -.19*                                                                                                                                                                                                                                                                                                                                                                                                                  -.03  .01 -.09 -  
6. sAAb -.08 -.01 -.11 .20* -.05 -  
7. Cortisolb  .02  .01 -.11 .47** -.01 .06 - 
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Table 4. Primary Model 2: MGPS x Condition Predicting sAA Reactivity 
 
b SE(b) t-value p-value 
Intercept 585.348 250.564 2.336 .021 
TSST Condition 784.901 336.589 2.332 .021 
MGPS (centered) 56.879 163.796 .347 .729 
MGPS x Condition -166.828 220.288 -.757 .450 
Note. Bolded values indicate p < .05 
 
Table 5. Primary Model 3: sAA x MGPS x Condition Predicting Cortisol Reactivity 
 
b SE(b) t-value p-value 
Intercept -39.385 22.263 -1.769 .079 
TSST Condition 179.272 29.120 6.156 <.001 
sAA (AUCi, centered) .018 .012 1.344 .181 
MGPS (centered) -7.105 15.049 -.472 .638 
MGPS x Condition 3.236 19.955 .162 .871 
Condition x sAA -.018 .015 -1.189 .236 
MGPS x sAA -.013 .010 -1.358 .177 
MGPS x Condition x sAA .027 .012 2.294 .023 
Note. Bolded values indicate p < .05. 
 
Table 6. Primary Model 3: sAA x MGPS x Condition Predicting Cortisol Reactivity (with 
SES covariate) 
 
b SE(b) t-value p-value 
Intercept -42.082 22.510 -1.869 .064 
SES (centered) .706 1.738 .406 .685 
SES x sAA .000 .001 .340 .734 
SES x MGPS -1.891 .776 -2.438 .016 
SES x Condition -1.283 2.309 -.556 .579 
TSST Condition 177.189 29.358 6.035 <.001 
sAA (AUCi, centered) .018 .014 1.324 .188 
sAA x MGPS -.015 .010 -1.540 .126 
sAA x Condition -.020 .016 -1.262 .209 
MGPS (centered) .923 15.303 .060 .952 
MGPS x Condition -10.162 20.641 -.492 .623 
MGPS x Condition x sAA .029 .012 2.462 .015 
Note. Bolded values indicate p < .05. 
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Table 7. Individual SNP x TSST Condition x sAA Interaction Terms, from Separate 
Models 
Gene SNP x TSST x sAA term b SE(b) t-value p-value 
NR3C1 rs10052957 x TSST x sAA  .054 .030 1.798 .075 
NR3C1 rs10482605 x TSST x sAA  -.015 .034 -.432 .666 
NR3C1 rs41423247 x TSST x sAA  -.021 .030 -.687 .493 
CRHR1 rs4792887 x TSST x sAA .051 .024 2.182 .031 
NR3C2 CA haplotype x TSST x sAA   -.034 .035 -.979 .330 
CRHR1 GAG haplotype x TSST x sAA .029 .025 1.166 .246 
CRHR1 TAT haplotype x TSST x sAA .015 .027 .560 .577 
Note. Bolded values indicate p < .05. 
Table 8. 10-SNP MGPS x Condition Predicting Cortisol Reactivity (Pagliaccio et al., 2014, 
2015a, 2015b; Starr & Huang, 2019) 
 
b SE(b) t-value p-value 
Intercept -48.003 20.431 -2.349 .020 
MGPS (centered) -3.263 8.647 -.377 .707 
TSST Condition 178.056 28.885 6.164 < .001 
MGPS x Condition -.671 12.007 -.056 .956 
Note. Bolded values indicate p < .05. 
 
Table 9. 10-SNP MGPS x Condition Predicting sAA Reactivity (Pagliaccio et al., 2014, 
2015a, 2015b; Starr & Huang, 2019) 
 
b SE(b) t-value p-value 
Intercept 596.411 239.242 2.493 .014 
MGPS (centered) 53.907 101.250 .532 .595 
TSST Condition 826.332 338.229 2.443 .016 
MGPS x Condition -1.932 140.592 -.014 .989 
Note. Bolded values indicate p < .05. 
 
Table 10. 3-SNP MGPS x Condition Predicting Cortisol Reactivity (Feurer et al., 2017) 
 
b SE(b) t-value p-value 
Intercept -49.682 20.498 -2.424 .017 
MGPS (centered) 1.577 8.990 .175 .861 
TSST Condition 177.938 29.066 6.122 < .001 
MGPS x Condition -1.498 12.850 -.117 .907 
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Table 11. 3-SNP MGPS x Condition Predicting sAA Reactivity (Feurer et al., 2017) 
 
  b   SE(b) t-value p-value 
Intercept 554.131 241.143 2.298 .023 
MGPS (centered) 147.369 105.760 1.393 .166 
TSST Condition 873.777 341.951 2.555 .012 
MGPS x Condition -137.229 151.173 -.908 .366 
Note. Bolded values indicate p < .05. 
 
Table 12. 2-SNP MGPS x Condition Predicting Cortisol Reactivity (Di Iorio et al., 2017) 
 
b     SE(b)    t-value  p-value 
Intercept -48.995 20.683 -2.369 .019 
MGPS (centered)  9.888 33.097 .299 .766 
TSST Condition 175.256 28.961 6.051 < .001 
MGPS x Condition -4.147 42.901 -.097 .923 
Note. Bolded values indicate p < .05. 
 
Table 13. 2-SNP MGPS x Condition Predicting sAA Reactivity (Di Iorio et al., 2017) 
 
b SE(b) t-value p-value 
Intercept 520.456 249.827 2.083 .039 
MGPS (centered) 718.511 399.776 1.797 .075 
TSST Condition 911.742 349.821 2.606 .010 
MGPS x Condition -674.948 518.196 -1.302 .195 
Note. Bolded values indicate p < .05. 
 
Table 14. Protective Haplotype x TSST Condition Predicting Cortisol Reactivity 
 
b SE(b) t-value p-value 
Intercept -49.852 20.337 -2.451 .015 
TSST Condition 181.305 28.875 6.279 < .001 
MGPS (centered) 27.889 52.826 .528 .598 
MGPS x Condition -63.208 79.903 -.791 .430 
Note. Bolded values indicate p < .05. 
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Table 15. Protective Haplotype x TSST Condition Predicting sAA Reactivity 
 
b SE(b) t-value p-value 
Intercept 594.654 237.526 2.504 .013 
TSST Condition 799.953 337.240 2.372 .019 
Haplotype (centered) 655.876 616.974 1.063 .290 
Haplotype x 
Condition 
-1213.351 933.211 -1.300 .196 
Note. Bolded values indicate p < .05.  
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Figure 1. Predicted Effect of HPA MGPS on Cortisol Reactivity by Condition 
In the negative evaluative (challenge) TSST condition, cortisol will be blunted for individuals 
with a high HPA MGPS score, whereas normative (high) cortisol responses will be observed for 
individuals in the negative evaluative condition with a low HPA MGPS score. Participants in the 
control condition will show a decline in cortisol over the repeated samplings consistent with 
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Figure 2. Predicted Effect of HPA MGPS on sAA Reactivity by Condition 
In the negative evaluative TSST condition, sAA will be relatively elevated for individuals with a 
high HPA MGPS, whereas individuals with low HPA MGPS will experience relatively lower 
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Figure 3. Predicted Effect of HPA MGPS on Cortisol Reactivity by sAA and Condition 
At high levels of sAA reactivity and high HPA MGPS, in the negative evaluative condition, 
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Figure 4. Cortisol Levels Across TSST Conditions  
Cortisol Levels across Condition. Samples included in cortisol calculation were collected 1) 
Before TSST (Baseline Sample, 0 min), 2) After the 5 min TSST preparation period (20 min 
from baseline), 3) After the two TSST tasks (45 min from baseline) and after additional study 
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Figure 5. Alpha-Amylase Level Across TSST Conditions Before, During, and after TSST 
The sAA samples were collected 1) Before TSST (Baseline Sample, 0), 2) +5 minutes from 
baseline (before the TSST), +20 minutes from baseline (following the TSST), and +45 minutes 
from baseline (after the TSST and other study tasks) when average levels have returned to 
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Figure 6. Observed Effect of HPA MGPS on Cortisol Reactivity (AUCi) by Condition 
Observed effect of HPA MGPS on cortisol reactivity by Condition in Individuals with Low (n = 
91) and High MGPS (n = 53). Low and High HPA MGPS groups were formed by median split. 
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Figure 7. Observed Effect of HPA MGPS on sAA Reactivity (AUCi) by Condition 
 Observed effect of HPA MGPS on sAA reactivity by Condition in Individuals with Low (n = 
91) and High MGPS (n = 53).  Low and High HPA MGPS groups were formed by median split. 
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sAA reactivity is mean centered. Values of sAA are: -1 standard deviation below the mean (-
2033.47 U/ml), at the mean (.00 U/ml), and +1 standard deviation above the mean (2033.47 
U/ml).  At high levels of sAA reactivity and high HPA MGPS, cortisol reactivity was robustly 
elevated in the negative evaluative condition relative to controls. At low sAA and low HPA 
MGPS, cortisol reactivity was robustly elevated in the negative evaluative condition relative to 
controls. At asymmetrical levels (low sAA/high MGPS; high sAA/low MGPS), cortisol 
reactivity appeared blunted in the negative evaluative condition. Johnson-Neyman regions of 
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Figure 7. Observed Effect of HPA MGPS on Cortisol Reactivity (AUCi) by sAA and 
Condition 
 
All high levels are +1 SD above the mean, and low levels are – 1 SD below the mean. At high 
levels of sAA reactivity and HPA MGPS, cortisol reactivity was elevated in the negative 
evaluative condition relative to controls. At low sAA and HPA MGPS, cortisol reactivity was 
elevated in the negative evaluative condition relative to controls. At asymmetrical levels (low 




















































APPENDIX B: CHALLENGE CONDITION BEHAVIORAL SCRIPT 
Speech portion:  
Both confederates begin with a mildly pleasant facial expression and neutral to interested body 
language, e.g., sit up and slightly lean forward in your chair 
 
Administer all directions with a firm, stern tone of voice. 
 
Possible timing in speech Confederate 1 (dissatisfied) Confederate 2 (bored) 
0:00 Scribble notes on your paper 
 
Slump shoulders & posture 
0:30 Furrow brow with slightly 
confused look 
 
Quiet sigh of fatigue 
1:00 Continue scribbling 
 
Stare into space 
1:30 Look more confused 
 
Play with hair 
2:00 Shuffle papers 
 
Slight eye roll 
2:30 Look at other confederate and 
shrug shoulders as if to ask, 
“what do you think?” 
 
Look at other confederate and 
slightly shake head “no” 
3:00 Subtle grimace; rub the 
bridge of your nose 
 
Cross arms, squirm 
3:30 Make a conspicuous X mark 
on your papers 
 
Look at your watch briefly 
4:00 Glance at your phone then put 
it away 
Widen eyes and breathe in 
and out deeply 
4:30 Exchange dissatisfied glance 
with another confederate 
 
Exchange dissatisfied glance 
with other confederate 
5:00 Tap fingers on table 
 
Fidget with fingernails 
 
Arithmetic portion:  Conspicuously make tally marks on your paperwork for errors/restarts. 
Maintain dissatisfied or bored body language and stern tone of voice.  
